These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2889251)

  • 1. [Pharmacodynamic effects of the beta-blocker mepindolol administered transdermally to healthy volunteers].
    Liedtke RK
    Schweiz Rundsch Med Prax; 1987 Jul; 76(30-31):854-6. PubMed ID: 2889251
    [No Abstract]   [Full Text] [Related]  

  • 2. [Human pharmacologic studies on transdermal administration of mepindolol. Pharmacodynamic and orienting pharmacokinetics].
    Liedtke RK; Chen LS; Mangold B; Haase W
    Arzneimittelforschung; 1989 Nov; 39(11A):1501-4. PubMed ID: 2576199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal delivery of mepindolol and propranolol in normal man. 1st communication: study design, clinical and pharmacodynamic aspects.
    de Mey C; Enterling D; Ederhof M; Wesche H; Osterwald H
    Arzneimittelforschung; 1989 Nov; 39(11A):1505-8. PubMed ID: 2576200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of mepindolol sulphate.
    Bonelli J; Hitzenberger G; Krause W; Wendt H; Speck U
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):169-76. PubMed ID: 6103882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic characterization of a new beta-receptor blocker: mepindolol at rest, during ergometer exercise and in the isoproterenol study in comparison with practolol and pindolol.
    Boneli J
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):325-31. PubMed ID: 19363
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.
    Spieker C; Vetter W; Zidek W; Vetter H
    Arzneimittelforschung; 1989 Nov; 39(11A):1512-4. PubMed ID: 2576202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinical and hemodynamic investigations on two beta-receptor blocking agents (pindolol and mepindolol) in normal subjects.
    Wink K
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):126-30. PubMed ID: 6715080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different beta-receptor antagonists on handgrip in essential hypertension.
    Fogari R; Marchesi E; Bellomo G; Parini A; Corradi L
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):551-3. PubMed ID: 6129200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocking potency of mepindolol and pindolol against isoproterenol-induced inotropic and chronotropic responses in guinea pig atria.
    Anderson WG
    J Cardiovasc Pharmacol; 1984; 6(1):7-11. PubMed ID: 6199615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transdermal treatment using the betablocker mepindolol].
    Arzneimittelforschung; 1989 Nov; 39(11A):1487-517. PubMed ID: 2576198
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of a single oral dose of pindolol].
    Safar M; Weiss Y; Milliez P
    Nouv Presse Med; 1978 Sep; 7(31):2767-8. PubMed ID: 30960
    [No Abstract]   [Full Text] [Related]  

  • 13. Isometric exercise before and after beta-receptor blockade with propranolol and mepindolol sulfate.
    Bonelli J
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):189-93. PubMed ID: 6143736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of two beta-adrenoceptor blockers (mepindolol and atenolol) on blood lipids and platelet aggregation in normal volunteers and essential hypertensive patients.
    Luque Otero M; Fernandez Pinilla C; Escriba Polo A; Rodriguez Vazquez M; Martell Claros N; Fernandez-Cruz A
    Br J Clin Pharmacol; 1984 Mar; 17(3):361-3. PubMed ID: 6143567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic effects of intravenous injection of beta-adrenergic inhibitor (Pindolol) in man].
    Scebat L; Rocha P; Ourbak P; Renais J; Lenègre J
    G Ital Cardiol; 1972; 2(5):626-35. PubMed ID: 4404052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preventive, long-term studies of ECG and heart rate using radiotelemetry during beta sympatholysis].
    Schäcke G; Bloedner CD; Valentin H; Ellner O
    Arztl Forsch; 1972 Nov; 26(11):394-401. PubMed ID: 4404593
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of pindolol given once daily in a dose of 15 mg in arterial hypertension].
    Barraine R; Bouchez C
    Nouv Presse Med; 1978 Sep; 7(31):2765-6. PubMed ID: 30959
    [No Abstract]   [Full Text] [Related]  

  • 18. Transdermal beta-blocker therapy in essential hypertension.
    Spieker C; Vetter H; Liedtke R; Zidek W; Vetter W
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):199S-200S. PubMed ID: 2901265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal delivery of mepindolol and propranolol in normal man. 2nd communication: pharmacokinetic and neuro-endocrine aspects.
    de Mey C; Meineke I; Enterling D; Rehbock C; Osterwald H
    Arzneimittelforschung; 1989 Nov; 39(11A):1508-12. PubMed ID: 2576201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pindolol in pediatrics. Evaluation of cardiac haemodinamics (author's transl)].
    Antoncecchi E; Mollica N; Ranieri L; Tagliente MR; Antoncecchi E
    Pediatr Med Chir; 1981; 3(6):551-4. PubMed ID: 6123984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.